Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-DA-22-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to support research to understand and respond to new challenges in the treatment of drug addiction and overdose, introduced by the now widespread presence of fentanyl and its analogs (fentanils) in illicit drug supplies. The UG3/UH3 Phased Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a project with specific milestones to be accomplished by the end of the 2-year period. The UH3 is to provide funding for 3 years to a project that successfully completed ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 12, 2021 Category: Research Source Type: funding
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional)
Funding Opportunity RFA-AI-21-058 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support research that combines epidemiologic methods, digital technology, and data science approaches to better understand HIV prevention, transmission, and early care-cascade points for women living in the US. Applications must: 1) determine the best ways to identify, enroll, and retain cohorts of women living in the United States (US) who are behaviorally vulnerable to HIV; and 2) knowledgebase comprised of cohort data from women augmented with other data sources including big data sources. F...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 12, 2021 Category: Research Source Type: funding
Resource Center for Tribal Epidemiological Centers (RC-TEC) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-MD-21-003 from the NIH Guide for Grants and Contracts. This initiative will support a single resource center to provide focused technical assistance and support to Tribal Epidemiology Centers (TECs) to enhance the research and data science capacity for health research focused on American Indian/Alaska Native (AI/AN) populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2021 Category: Research Source Type: funding
Brazil Regional Prospective Observational Research in Tuberculosis (RePORT) (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-304 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support a Brazil-US Regional Prospective Observational Research in Tuberculosis (RePORT) network that will leverage the robust clinical research infrastructure of Brazil to advance our current understanding of the community, host and microbial factors that impact outcomes of tuberculosis (TB) infection and TB disease, especially among persons with HIV (PWH), including drug-resistant TB, to facilitate development of tools to improve treatment outcomes at the individual level and to inform strategie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 5, 2021 Category: Research Source Type: funding
Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities
New and competing continuation funding for Tribal Epidemiology Centers (TECs) serving American Indian/Alaska Native (AI/AN) tribes and urban Indian communities. TECs will conduct disease surveillance, research, and prevention; control of disease, injury, or disability; and assess the effectiveness of AI/AN public health programs. Geographic coverage: Nationwide -- Indian Health Service, U.S. Department of Health and Human Services (Source: Funding opportunities via the Rural Health Information Hub)
Source: Funding opportunities via the Rural Health Information Hub - August 3, 2021 Category: American Health Source Type: funding
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-22-003 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to solicit research to better understand the epidemiology and biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 29, 2021 Category: Research Source Type: funding
Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-22-004 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to solicit research to better understand the epidemiology and biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2021 Category: Research Source Type: funding
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-204 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) supports investigator-initiated, complex, multi-center and other high resource risk epidemiologic studies under the cooperative agreement mechanism, UG1 activity code. Specifically, the purpose of this Funding Opportunity Announcement (FOA) is to support new and innovative ocular epidemiology research. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 28, 2021 Category: Research Source Type: funding
India Collaborative Vision Research Program (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-249 from the NIH Guide for Grants and Contracts. This funding Opportunity Announcement (FOA) encourages Multiple Principal Investigator (Multi-PD/PI) applications from United States (U.S.) and Indian institution as bilateral collaborations that will advance science and technology important to understanding, preventing, and treating blinding eye diseases, visual disorders, and their complications. Areas of Research Collaboration: Applications are encouraged from organization/institutions that propose to conduct research on the basic biology and/or genetics of ophthalmic diseases through collab...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 25, 2021 Category: Research Source Type: funding
PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional)
Funding Opportunity RFA-DA-22-017 from the NIH Guide for Grants and Contracts. NIDA is interested in research that addresses research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the ef...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 16, 2021 Category: Research Source Type: funding
Innovative Models for Delivering PrEP and STI Services to Stop HIV in the United States (R61/R33 Clinical Trial Optional)
Funding Opportunity RFA-AI-20-069 from the NIH Guide for Grants and Contracts. The purpose of this FOA is encourage and support the development of effective strategies for expanding the provision of HIV pre-exposure prophylaxis (PrEP) in sexually transmitted infection (STI) service settings in high priority jurisdictions identified by the presidential initiative, Ending the HIV Epidemic: A Plan for America. Funding for the fourth and fifth years (s) will be dependent upon achieving negotiated go/no go criteria and milestones. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 15, 2021 Category: Research Source Type: funding
Housing Opportunities for Persons With AIDS Competitive Grant: Housing as an Intervention to Fight AIDS
Funding to create and implement new projects that align with initiatives aimed at ending the HIV/AIDS epidemic using housing as an intervention in ending the epidemic. HUD is looking to fund innovative projects including community-level coordination, data collection with emphasis on stable housing and positive health outcomes, culturally competent approaches to providing housing and services, and a systemic approach to advance equity in underserved communities that can serve as a national place-based model. Geographic coverage: Nationwide -- U.S. Department of Housing and Urban Development (Source: AIDS and HIV funding opp...
Source: AIDS and HIV funding opportunities via the Rural Assistance Center - April 16, 2021 Category: Infectious Diseases Source Type: funding
Limited Interaction Targeted Epidemiology (LITE-2): To Advance HIV Prevention (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-AI-21-018 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that use innovative technology to conduct epidemiologic studies of large cohorts of U.S. populations at high risk of HIV: men who have sex with men (MSM), people who inject drugs (PWID), and transgender women and men, focusing especially on the minority and age groups at highest risk of HIV transmissions. The major goal is to support investigators who will use innovative electronic methods to recruit and retain large samples of persons at high risk of HIV, c...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 7, 2021 Category: Research Source Type: funding
Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
Funding Opportunity PA-21-201 from the NIH Guide for Grants and Contracts. Reissue of the PA-18-401. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2021 Category: Research Source Type: funding
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
Funding Opportunity PA-21-200 from the NIH Guide for Grants and Contracts. Reissue of the PA-18-400. The purpose of this Funding Opportunity Announcement (FOA) is to encourage research grant applications to support research designed to elucidate the etiology, epidemiology, diagnosis, and optimal means of service delivery in relation to Autism Spectrum Disorders (ASD). (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 31, 2021 Category: Research Source Type: funding
